Takeaways: Sanofi’s new Charles Best Building in Toronto adds end‑to‑end flu vaccine manufacturing capacity in Canada and is set to become the central hub for producing Fluzone High‑Dose for adu...
Takeaways: The main market signal is strategic rather than commercial: Health Canada’s clearance, alongside PHAC’s collaboration with Moderna, helps de-risk the company’s mRNA infectious-disease...
The COVID-19 pandemic fundamentally transformed the global vaccine industry, accelerating scientific innovation, manufacturing investment, and public awareness at an unprecedented pace. Technologies t...
